Buthionine sulfoximine (BSO) inhibits proliferation of human lung carc
inoma A549 cells, and exogenous glutathione (GSH) overcomes the antipr
oliferative effect. The BSO antiproliferation may result from inhibiti
on of cellular uptake of amino acids, and the antagonistic effect of G
SH would result from supplementation of amino acids via the gamma-glut
amyl cycle. To explore these possibilities, the present study was unde
rtaken to determine effects of BSO on glutamate- and GSH-stimulated ce
ll proliferation, A549 cells were cultured in a glutamine-deficient Du
lbecco's modified Eagle's medium (Gln(-)-DMEM), in which they did not
proliferate. Addition of glutamate or GSH in the medium to a concentra
tion of 4 mM stimulated cell proliferation, BSO of 0.1 mM enhanced the
GSH-stimulated cell proliferation and attenuated the glutamate-stimul
ated cell proliferation. This BSO effect correlated with changes in ce
llular glutamate levels; that is, BSO increased and decreased glutamat
e concentrations, respectively, in GSH- and glutamate-stimulated cells
, GSH or glutamate alone significantly increased cellular GSH levels,
BSO depleted cellular GSH in both GSH- and glutamate-stimulated cells
to the same level. These changes in GSH levels did not correlate with
the respective growth modulatory effect. Because BSO inhibits cellular
uptake of some amino acids and the A549 cells contain high levels of
gamma-glutamyl transpeptidase activity, the results suggest that the B
SO inhibition of glutamate-stimulated cell proliferation may result fr
om decreased glutamate uptake. GSH would supplement the cells with glu
tamate via the gamma-glutamyl pathway to bypass the inhibition of amin
o acid uptake and overcome the BSO-antiproliferative effect.